Hyperglucagonemia, which is believed to derive mainly from a loss of insulin-mediated intra-islet suppression of glucagon production [24, 25, 36], is increasingly recognized as an important cause of hyperglycemia [26], and we have reported hyperglucagonemia as a phenotypic feature in MIDY patients [11]. Here, INS is linked to Hyperglycemia.